Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for several difficult-to-treat infections in humans. It is also called multidrug-resistant S. aureus and oxacillin-resistant S. aureus (ORSA). MRSA is any strain of S. aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins and the cephalosporins. MRSA is especially troublesome in hospitals and nursing homes, where patients with open wounds, invasive devices and weakened immune systems are at greater risk of infection than the general public.
AmpliSens® MRSA-screen-titre-FRT kit can detect and quantify methicillin-susceptible and methicillin-resistant S. aureus DNA, methicillin-resistant coagulase-negative Staphylococcus spp. in oropharyngeal swab, BAL fluid, sputum, endotracheal aspirate, bronchial washings, urine, blood, plasma, CS fluid, punctates, tissues, wipes from medical equipment.